Health Condition 1: J454- Moderate persistent asthma
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed patients of Bronchial Asthma on combination inhaler of ICS/LABA (Budesonide 200mcg & Formoterol Fumarate 6mcg). Age group : Young adult 20 to 39 years. WHO Ayurveda symptoms score for Tamaka Shwasa less than 47 Peak Expiratory Flow Rate more than 300L/min Blood oxygen saturation (Spo2) more than 92 percent.
Exclusion criteria
Exclusion criteria: Patients of Acute Severe Asthma. WHO Ayurveda symptom score for Tamaka Shwasa more than 47 H/O Tuberculosis, Chronic Obstructive Pulmonary Disease, Emphysema, other complicated respiratory diseases. K/C/O Hypertension, Diabetes mellitus & Cardiac involvement. Patients with frequent H/O hospitalisation due to Status Asthmaticus. Patients classically contraindicated for Haritaki administration (pregnancy, underweight, who has undergone bloodletting, condition of excessive hunger, thirst & heat stroke).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study may be useful to control asthma especially during Shishir Ritu when symptoms get flared up due to cold weather.Timepoint: This study may be useful to control asthma especially during Shishir Ritu when symptoms get flared up due to cold weather. The outcome will be assessed at 8 weeks and follow up will be taken after every 20 days in Shishir Ritu. | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Shri Ayurved Mahavidyalaya, Nagpur